Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

导出 OA

翻译打印收藏纠错

第一作者： Shunichi,Sugawara

第一单位： Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.

作者： Shunichi,Sugawara ^[1] ; Kazuhiko,Nakagawa ^[2] ; Nobuyuki,Yamamoto ^[3] ; Hiroshi,Nokihara ^[4] ; Yuichiro,Ohe ^[4] ; Makoto,Nishio ^[5] ; Toshiaki,Takahashi ^[6] ; Koichi,Goto ^[7] ; Makoto,Maemondo ^[8] ; Yukito,Ichinose ^[9] ; Takashi,Seto ^[10] ; Hiroshi,Sakai ^[11] ; Akihiko,Gemma ^[12] ; Fumio,Imamura ^[13] ; Masato,Shingyoji ^[14] ; Hideo,Saka ^[15] ; Akira,Inoue ^[16] ; Koji,Takeda ^[17] ; Isamu,Okamoto ^[18] ; Katsuyuki,Kiura ^[19] ; Satoshi,Morita ^[20] ; Tomohide,Tamura ^[21]

作者单位： Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan. ^[1] Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan. ^[2] Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan. ^[3] Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. ^[4] Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. ^[5] Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan. ^[6] Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ^[7] Department of Respiratory Medicine, Miyagi Cancer Center, Miyagi, Japan. ^[8] Department of Cancer Information Research, National Kyushu Cancer Center, Clinical Research Institute, Fukuoka, Japan. ^[9] Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan. ^[10] Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan. ^[11] Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan. ^[12] Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan. ^[13] Division of Respirology, Chiba Cancer Center, Chiba, Japan. ^[14] Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan. ^[15] Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan. ^[16] Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan. ^[17] Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ^[18] Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan. ^[19] Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan. ^[20] Thoracic Center, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan. tamuratomohide@gmail.com. ^[21]

关键词 Chemotherapy Japan Phase III Second line Tegafur–gimeracil–oteracil Third line